Mwanzo068270 • KRX
add
Celltrion Inc
Bei iliyotangulia
₩ 175,600.00
Bei za siku
₩ 175,100.00 - ₩ 178,800.00
Bei za mwaka
₩ 157,500.00 - ₩ 241,000.00
Thamani ya kampuni katika soko
38.86T KRW
Wastani wa hisa zilizouzwa
elfu 538.81
Uwiano wa bei na mapato
195.87
Mgao wa faida
0.28%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 881.93B | 31.18% |
Matumizi ya uendeshaji wa biashara | 255.73B | 148.90% |
Mapato halisi | 85.59B | -61.41% |
Kiwango cha faida halisi | 9.71 | -70.58% |
Mapato kwa kila hisa | 414.00 | -73.48% |
EBITDA | 283.35B | -13.69% |
Asilimia ya kodi ya mapato | 52.82% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.18T | 190.82% |
Jumla ya mali | 20.31T | 209.79% |
Jumla ya dhima | 3.28T | 57.87% |
Jumla ya hisa | 17.03T | — |
hisa zilizosalia | 206.09M | — |
Uwiano wa bei na thamani | 2.14 | — |
Faida inayotokana na mali | 2.57% | — |
Faida inayotokana mtaji | 2.70% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 85.59B | -61.41% |
Pesa kutokana na shughuli | 265.31B | 653.96% |
Pesa kutokana na uwekezaji | -136.41B | -38.41% |
Pesa kutokana na ufadhili | -47.95B | 61.66% |
Mabadiliko halisi ya pesa taslimu | 68.24B | 125.70% |
Mtiririko huru wa pesa | 265.58B | 234.44% |
Kuhusu
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Tovuti
Wafanyakazi
1,074
